Tyler Ko is the General Manager of Pentec’s Metabolic Disorders business with nearly a decade of experience in the healthcare industry. He spent nine years at Baxter International, where he led multiple strategic acquisition and divestiture initiatives and drove growth through business development, financial planning, and investor relations. Tyler brings deep expertise in corporate strategy and operational execution and is committed to advancing innovative solutions in patient care.